Implementing lifestyle interventions in mental health care: third report of the Lancet Psychiatry Physical Health Commission
- PMID: 40812962
- DOI: 10.1016/S2215-0366(25)00170-1
Implementing lifestyle interventions in mental health care: third report of the Lancet Psychiatry Physical Health Commission
Erratum in
-
Correction to Lancet Psychiatry 2025; 12: 700-22.Lancet Psychiatry. 2026 Mar;13(3):e6. doi: 10.1016/S2215-0366(26)00028-3. Epub 2026 Feb 9. Lancet Psychiatry. 2026. PMID: 41679319 No abstract available.
Conflict of interest statement
Declaration of interests SBT is funded by a National Health and Medical Research Council (NHMRC) EL1 Investigator Fellowship (APP2017302). KKM is supported partially by National Institute for Health and Care Research (NIHR) grants NIHR201618 and NIHR206943. AM is supported partially by the Australian Government through the Australian Research Council's Centre of Excellence for Children and Families over the Life Course (Project ID CE200100025), the Medical Research Future Fund Clinician Researchers Applied Research in Health (Project ID: MRF2032279), and an NHMRC Targeted Call for Research for Improving physical health of people with a mental illness 2022 (ID 2025098). ALO is funded by the National Institute of Health National Heart, Lung, and Blood Institute Award (1R21HL175536–01). FBS is part funded by Conselho Nacional de Ciência e Tecnologia grant 314105/2023–9 and by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior grant 0001. SG was Director of the UK Research and Innovation (UKRI) Closing the Gap Network [2019–24] that addresses health inequalities for people with severe mental illness [UKRI Grant ES/S004459/1]. BS is supported by an NIHR Advanced Fellowship (NIHR301206). SR is funded by an NHMRC EL2 Investigator Fellowship (APP2017506); and has provided consultancy to the Olympic Refugee Foundation. SC (NIHR303122) is funded by the NIHR for this research project; is supported by NIHR grants NIHR203684, NIHR203035, NIHR130077, NIHR128472, and RP-PG-0618–20003 and by grant 101095568-HORIZONHLTH- 2022-DISEASE-07–03 from the European Research Executive Agency; received reimbursement for travel and accommodation expenses from the Association for Child and Adolescent Central Health (ACAMH) in relation to lectures delivered for ACAMH, the Canadian AADHD Alliance Resource, the British Association of Psychopharmacology, Healthcare Convention and CCM Group team for educational activity on ADHD; and has received honoraria from Medice. JF is supported by a UK Research and Innovation Future Leaders Fellowship (MR/Y033876/1) and the NIHR Manchester Biomedical Research Centre (NIHR203308); and has provided consultancy, speaking engagements and/or advisory services to Atheneum, Bayer, ParachuteBH, LLMental, Nestle UK, HedoniaUS, and Arthur D Little. WM is currently funded by an NHMRC Investigator Grant (#2008971); received funding from the Cancer Council Queensland and university grants/fellowships from La Trobe University, Deakin University, University of Queensland, and Bond University; received funding and/or has attended events funded by Cobram Estate and Bega Dairy and Drinks; received travel funding from the Nutrition Society of Australia; received consultancy funding from Nutrition Research Australia and ParachuteBH; and received speakers honoraria from VitaFoods, The Cancer Council Queensland, and the Princess Alexandra Research Foundation. EM is funded by the Government of Ireland and the European Union through the ERDF Southern, Eastern & Midland Regional Programme 2021–27 and the Northern & Western Regional Programme 2021–27 as part of TU RISE. All other authors declare no competing interests.
Publication types
LinkOut - more resources
Full Text Sources
